GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Total Liabilities

Medinet Co (TSE:2370) Total Liabilities : 円533.0 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co Total Liabilities?

Medinet Co's Total Liabilities for the quarter that ended in Mar. 2024 was 円533.0 Mil.

Medinet Co's quarterly Total Liabilities declined from Sep. 2023 (円590.20 Mil) to Dec. 2023 (円548.63 Mil) and declined from Dec. 2023 (円548.63 Mil) to Mar. 2024 (円533.02 Mil).

Medinet Co's annual Total Liabilities increased from Sep. 2021 (円474.95 Mil) to Sep. 2022 (円566.14 Mil) and increased from Sep. 2022 (円566.14 Mil) to Sep. 2023 (円590.20 Mil).


Medinet Co Total Liabilities Historical Data

The historical data trend for Medinet Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co Total Liabilities Chart

Medinet Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 493.72 442.99 474.95 566.14 590.20

Medinet Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 528.81 563.97 590.20 548.63 533.02

Medinet Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Medinet Co's Total Liabilities for the fiscal year that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=346.838+(0.781+242.585
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=590.2

Total Liabilities=Total Assets (A: Sep. 2023 )-Total Equity (A: Sep. 2023 )
=5634.145-5043.941
=590.2

Medinet Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=256.745+(0+276.276
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=533.0

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=6100.265-5567.244
=533.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Medinet Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co (TSE:2370) Business Description

Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co (TSE:2370) Headlines

No Headlines